Insider Transactions in Q2 2025 at Viridian Therapeutics, Inc.\De (VRDN)
Insider Transaction List (Q2 2025)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 10
2025
|
Fairmount Funds Management LLC Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
12,500
+0.36%
|
$150,000
$12.31 P/Share
|
Jun 09
2025
|
Fairmount Funds Management LLC Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
1,600
+0.05%
|
$11,200
$7.8 P/Share
|